Possible association of the alpha-2A-adrenergic receptor gene with response time variability in attention deficit hyperactivity disorder

American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics

Volumn 147, Issue 6, 2008, Pages 957-963

  Cho, Soo Churl ^a   Kim, Jae Won ^a   Kim, Boong Nyun ^a   Hwang, Jun Won ^a   Park, Mira ^b   Kim, Soon Ae ^b   Cho, Dae Yeon ^c   Yoo, Hee Jeong ^d   Chung, Un Sun ^e   Son, Jung Woo ^f   Park, Tae Won ^g  

^a Seoul National University Hospital   (South Korea)

^b Eulji University   (South Korea)

^c LabGenomics Clinical Research Institute   (South Korea)

^d Seoul National University Bundang Hospital   (South Korea)

^e Kyungpook National University Hospital   (South Korea)

^f Chungbuk National University Hospital   (South Korea)

^g Chonbuk National University Medical School   (South Korea)

Author keywords

ADRA2A; Attention deficit hyperactivity disorder; Continuous performance test; Haplotype; Transmission disequilibrium

Indexed keywords

ALPHA 2A ADRENERGIC RECEPTOR; GENOMIC DNA;

ARTICLE; ASIAN; ATTENTION DEFICIT DISORDER; CASE CONTROL STUDY; CHILD; COGNITION; CONTROLLED STUDY; DNA SEQUENCE; FAMILY STUDY; FEMALE; GENE LINKAGE DISEQUILIBRIUM; GENETIC POLYMORPHISM; GENOTYPE; HAPLOTYPE; HUMAN; HUMAN CELL; HYPERACTIVITY; KOREA; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RECEPTOR GENE; RESPONSE TIME; SYMPTOM; TASK PERFORMANCE;

ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CASE-CONTROL STUDIES; CHILD; DEOXYRIBONUCLEASE HPAII; DEOXYRIBONUCLEASES, TYPE II SITE-SPECIFIC; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; KOREA; LINKAGE DISEQUILIBRIUM; MALE; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; REACTION TIME; RECEPTORS, ADRENERGIC, ALPHA-2;

EID: 51449099153     PISSN: 15524841     EISSN: 1552485X     Source Type: Journal    
DOI: 10.1002/ajmg.b.30725     Document Type: Article

References (53)

1. Achenbach TM. 1991. Manual for the child behavior checklist/4-18 and 1991 profile. Burlington: University of Vermont.
2. American Psychiatric Association. 1994. Diagnostic and statistical manual of mental disorders, 4th edition. Washington, DC: American Psychiatric Association Press.
3. Arnsten AF. 1998. Catecholamine modulation of prefrontal cortical cognitive function. Trends Cogn Sci 2:436-447.
4. Arnsten AF. 2000. Genetics of childhood disorders: XVIII. ADHD, Part 2: Norepinephrine has a critical modulatory influences on prefrontal cortical function. J Am Acad Child Adolesc Psychiatry 39:1201-1203.
5. Arnsten AFT. 2001. Dopaminergic and noradrenergic influences on cognitive functions mediated by prefrontal cortex. In: Solanto MV, Arnsten AFT, Castellanos FX, editors. Stimulant drugs and ADHD: Basic and clinical neuroscience. New York: Oxford University Press, pp 185-208.
6. Arnsten AF, Steere JC, Hunt RD. 1996. The contribution of alpha 2-noradrenergic mechanisms of prefrontal cortical cognitive function. Potential significance for attention-deficit hyperactivity disorder. Arch Gen Psychiatry 53:448-455.
7. Barkley RA. 1997. Behavioral inhibition, sustained attention, and executive functions: Constructing a unifying theory of ADHD. Psychol Bull 121:65-94.
8. Bellgrove MA, Hester R, Garavan H. 2004. The functional neuroanatomical correlates of response variability: Evidence from a response inhibition task. Neuropsychologia 42:1910-1916.
9. Bellgrove MA, Hawi Z, Kirley A, Gill M, Robertson IH. 2005a. Dissecting the attention deficit hyperactivity disorder (ADHD) phenotype: Sustained attention, response variability and spatial attentional asymmetries in relation to dopamine transporter (DAT1) genotype. Neuropsychologia 43:1847-1857.
10. Bellgrove MA, Hawi Z, Lowe N, Kirley A, Robertson IH, Gill M. 2005b. DRD4 gene variants and sustained attention in attention deficit hyperactivity disorder (ADHD): Effects of associated alleles at the VNTR and -521 SNP. Am J Med Genet Part B 136B:81-86.
11. Berwid OG, Curko Kera EA, Marks DJ, Santra A, Bender HA, Halperin JM. 2005. Sustained attention and response inhibition in young children at risk for attention deficit/hyperactivity disorder. J Child Psychol Psychiatry 46:1219-1229.
12. Biederman J, Faraone SV. 2005. Attention-deficit hyperactivity disorder. Lancet 366:237-248.
13. Biederman J, Spencer T. 1999. Attention-deficit/hyperactivity disorder (ADHD) as a noradrenergic disorder. Biol Psychiatry 46:1234-1242.
14. Biederman J, Spencer TJ. 2000. Genetics of childhood disorders: XIX. ADHD, Part 3: Is ADHD a noradrenergic disorder? J Am Acad Child Adolesc Psychiatry 39:1330-1333.
15. Bobb AJ, Castellanos FX, Addington AM, Rapoport JL. 2005. Molecular genetic studies of ADHD: 1991-2004. Am J Med Genet Part B 132B:109-125.
16. Castellanos FX, Tannock R. 2002. Neuroscience of attention-deficit/ hyperactivity disorder: The search for endophenotypes. Nat Rev Neurosci 3:617-628.
17. Castellanos FX, Sonuga-Barke EJ, Scheres A, Di Martino A, Hyde C, Walters JR. 2005. Varieties of attention-deficit/hyperactivity disorder-related intra-individual variability. Biol Psychiatry 57:1416-1423.
18. Cho SC, Choi JS. 1989. Development of the Korean version of State-Trait Anxiety Inventory for Children. Seoul Rev Psychiatry 14:150-157.
19. Cho SC, Lee YS. 1990. Development of the Korean version of Children's Depression Inventory. J Korean Neuropsychiatr Assoc 29:943-956.
20. Clayton D. 1999. A generalization of the transmission/disequilibrium test for uncertain-haplotype transmission. Am J Hum Genet 65:1170-1177.
21. Deupree JD, Smith SD, Kratochvil CJ, Bohac D, Ellis CR, Polaha J, Bylund DB, UNMC Collaborative ADHD Research Team. 2006. Possible involvement of alpha-2A adrenergic receptors in attention deficit hyperactivity disorder: Radioligand binding and polymorphism studies. Am J Med Genet Part B 141B:877-884.
22. Doyle AE, Faraone SV, Seidman LJ, Willcutt EG, Nigg JT, Waldman ID, Pennington BF, Peart J, Biederman J. 2005a. Are endophenotypes based on measures of executive functions useful for molecular genetic studies of ADHD? J Child Psychol Psychiatry 46:774-803.
23. Doyle AE, Willcutt EG, Seidman LJ, Biederman J, Chouinard VA, Silva J, Faraone SV. 2005b. Attention-deficit/hyperactivity disorder endophenotypes. Biol Psychiatry 57:1324-1335.
24. DuPaul GJ. 1991. Parent and teacher ratings of ADHD symptoms: Psychometric properties in a community-based sample. J Clin Child Psychol 20:245-253.
25. Faraone SV, Doyle AE. 2001. The nature and heritability of attention-deficit/hyperactivity disorder. Child Adolesc Psychiatr Clin N Am 10:299-316.
26. Gottesman II, Gould TD. 2003. The endophenotype concept in psychiatry: Etymology and strategic intentions. Am J Psychiatry 160:636-645.
27. Greenberg LM, Waldman ID. 1993. Developmental normative data on the test of variables of attention (TOVA). J Child Psychol Psychiatry 34:1019-1030.
28. Ha EH, Oh KJ, Hong KE, Lee HR. 1996. Reconstruction of behavioral syndrome scales of Korean version of Child Behavior Checklist (K-CBCL). Seoul Rev Psychiatry 20:45-52.
29. Hoehe MR, Berrettini WH, Lentes KU. 1998. DraI identifies a two allele DNA polymorphism in the human alpha 2-adrenergic receptor gene (ADRAR), using a 5.5 kb probe (p ADRAR). Nucleic Acids Res 16:9070.
30. Kaufman J, Birmaher B, Brent D, Rao U, Flynn C, Moreci P, Williamson D, Ryan N. 1997. Schedule for Affective Disorders and Schizophrenia for School-Age Children-Present and Life Time Version (K-SADS-PL): Initial reliability and validity data. J Am Acad Child Adolesc Psychiatry 36:980-988.
31. Kim YS, Cheon KA, Kim BN, Chang SA, Yoo HJ, Kim JW, Cho SC, Seo DH, Bae MO, So YK, Noh JS, Koh YJ, McBurnett K, Leventhal B. 2004. The reliability and validity of Kiddie-Schedule for Affective Disorders and Schizophrenia - Present and Lifetime Version - Korean Version (K-SADS-PL-K). Yonsei Med J 45:81-89.
32. Kovacs M. 1985. The children's depression inventory. Psychopharmacol Bull 21:995-998.
33. Kuntsi J, Stevenson J. 2001. Psychological mechanisms in hyperactivity: II. The role of genetic factors. J Child Psychol Psychiatry 42:211-219.
34. Lario S, Calls J, Cases A, Oriola J, Torras A, Rivera F. 1997. MspI identifies a biallelic polymorphism in the promotor region of the alpha 2A-adrenergic receptor gene. Clin Genet 51:129-130.
35. Loo SK, Specter E, Smolen A, Hopfer C, Teale PD, Reite ML. 2003. Functional effects of the DAT1 polymorphism on EEG measures in ADHD. J Am Acad Child Adolesc Psychiatry 42:986-993.
36. Oades RD. 2000. Differential measures of 'sustained attention' in children with attention-deficit hyperactivity or tic disorders: Relations to monoamine mechanism. Psychiatry Res 93:165-178.
37. Oh KJ, Lee HR. 1990. Development of Korean version of Child Behavior Checklist (K-CBCL). Seoul: Korean Research Foundation Report.
38. Park L, Nigg JT, Waldman ID, Nummy KA, Huang-Pollock C, Rappley M, Friderici KH. 2005. Association and linkage of alpha-2A adrenergic receptor gene polymorphisms with childhood ADHD. Mol Psychiatry 10:572-580.
39. Pliszka SR, McCracken JT, Maas JW. 1996. Catecholamines in the attention-deficit hyperactivity disorder: Current perspectives. J Am Acad Child Adolesc Psychiatry 35:264-272.
40. Roman T, Schimitz M, Polanczyk GV, Eizirik M, Rohde LA, Hutz MH. 2003. Is the alpha-2A adrenergic receptor gene (ADRA2A) associated with attention-deficit hyperactivity disorder? Am J Med Genet Part B 120B:116-120.
41. Sawyer SL, Mukherjee N, Pakstis AJ, Feuk L, Kidd JR, Brookes AJ, Kidd KK. 2005. Linkage disequilibrium patterns vary substantially among populations. Eur J Hum Genet 13:677-686.
42. Schmitz M, Denardin D, Silva TL, Pianca T, Roman T, Hutz MH, Faraone SV, Rohde LA. 2006. Association between alpha-2A adrenergic receptor gene and ADHD inattentive type. Biol Psychiatry 60:1028-1033.
43. Shin MS, Cho S, Chun SY, Hong KE. 2000. A study of the development and standardization of ADHD diagnostic system. Korean J Child Adolesc Psychiatr 11:91-99.
44. Smalley SL. 1997. Genetic influences in childhood-onset psychiatric disorders: Autism and attention-deficit hyperactivity disorder. Am J Hum Genet 60:1276-1282.
45. So YK, Noh JS, Kim YS, Ko SG, Koh SJ. 2002. The reliability and validity of Korean parent and teacher ADHD Rating Scale. J Korean Neuropsychiatr Assoc 41:283-289.
46. Solanto M. 1998. Neuropsychopharmacological mechanisms of stimulant drug action in attention-deficit hyperactivity disorder: A review and intergration. Behav Brain Res 94:127-152.
47. Spielberger CD. 1972. Manual for the state-trait anxiety inventory for children. Palo Alto, CA: Consulting Psychological Press.
48. Spielman RS, McGinnis RE, Ewens WJ. 1993. Transmission test for linkage disequilibrium: The insulin gene region and insulin-dependent diabetes mellitus (IDDM). Am J Genet 52:506-516.
49. State MW, Lombroso PJ, Pauls DL, Leckman JF. 2000. The genetics of childhood psychiatric disorders: A decade of progress. J Am Acad Child Adolesc Psychiatry 39:946-962.
50. Stuss DT, Murphy KJ, Binns MA, Alexander MP. 2003. Staying on the job: The frontal lobes control individual performance variability. Brain 126:2363-2380.
51. Usher M, Cohen JD, Servan-Schreiber D, Rajkowski J, Aston-Jones G. 1999. The role of locus coeruleus in the regulation of cognitive performance. Science 283:549-554.
52. Waldman ID, Nigg JT, Gizer IR, Park L, Rappley MD, Friderici K. 2006. The adrenergic receptor alpha-2A gene (ADRA2A) and neuropsychological executive functions as putative endophenotypes for childhood ADHD. Cogn Affect Behav Neurosci 6:18-30.
53. Wang B, Wang Y, Zhou R, Li J, Qian Q, Yang L, Guan L, Faraone SV. 2006. Possible association of the alpha-2A adrenergic receptor gene (ADRA2A) with symptoms of attention-deficit/hyperactivity disorder. Am J Med Genet Part B 141B:130-134.